|
|
.
NPI Detail
NPI: 1295789907
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
1000 XXXXXX XXXX
CHARLOTTE, NC 282035812
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1295789907*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXX.X
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J1453
|
Fosaprepitant injection
|
XXXXXX
|
$XXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXXX
|
$XXXXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXXX
|
$XXXXXX.XX
|
| J7205
|
Factor viii fc fusion recomb
|
XXXXXX
|
$XXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXXX
|
$XXXXXXX.XX
|
| J0485
|
Belatacept injection
|
XXXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J1459
|
Inj ivig privigen 500 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J9119
|
Inj., cemiplimab-rwlc, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9047
|
Injection, carfilzomib, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J0256
|
Alpha 1 proteinase inhibitor
|
XXXXX
|
$XXXXXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXXX
|
-
|
| J7192
|
Factor viii recombinant nos
|
XXXXX
|
$XXXXX.XX
|
| J9171
|
Docetaxel injection
|
XXXXX
|
-
|
| J0257
|
Glassia injection
|
XXXXX
|
$XXXXXX.XX
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J2323
|
Natalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J2357
|
Omalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXXX
|
$XXXXXXX.XX
|
| J7187
|
Humate-p, inj
|
XXXXX
|
$XXXXX.XX
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
